Beckman Coulter Life Sciences, a global leader in laboratory automation
and innovation and a subsidiary of Danaher Corporation (NYSE: DHR), continues
to lead the way with first-to-market concepts with the launch of the CytoFLEX
nano Flow Cytometer—the first purpose-built nanoscale flow cytometer for
research use only that enables detection to at least 40 nm*, enabling 30-50
percent more data creation compared to current marketplace offerings. With unrivaled sensitivity to detect, count, and characterize
nanoparticles using a single analytical instrument, the CytoFLEX nano Flow
Cytometer offers simultaneous multiparameter detection powered by six
fluorescent detection channels and five side scatter channels. It provides
global laboratories with a first-of-its kind solution that lowers the limit of
detection and increases resolution to characterize lower abundance targets in
heterogeneous extracellular vesicle (EV) populations between 1 μm and 40 nm
(polystyrene when triggering on violet side scatter). “The CytoFLEX nano Flow Cytometer shatters the previous limits of
detection capabilities, arming researchers with data they previously would have
never been able to access,” said product manager Matthew Goff. “This can open
new doors for researchers and enable breakthrough discoveries in our battle
against a myriad of diseases. Extracellular vesicles can be found everywhere,
and now researchers finally have a tool to see what has always been right in
front of them. We listened to the needs of our customers to create an
analytical crossroads by increasing sensitivity through enhanced fluidics,
optics, and electronics.” Nanoparticles are introduced in a hydrodynamic focused stream to the
optical system composed of lasers and detectors. Emitted signals are collected,
digitized, and displayed by the electronics and instrument control software,
CytExpert. Multiple automatic on-board cleaning options are offered to control
sample-to-sample carryover and maintain a clean sample line. “We need to go smaller to expand the realms of research, and there are
very few instruments built for small particle detection alone,” said Alfonso
Blanco, director of the Flow Cytometry Core Technologies in the University
College Dublin. “The CytoFLEX nano Flow Cytometer offers a gold mine of
research discoveries, including the ability to develop complex biomarkers from
blood or urine rather than more invasive tissue means, which means less pain
for patients, along with richer results.” The ergonomic design reduces noise, identifies backgrounds, and reduces
carryover issues. Consistent instrument performance from extensive automated QC
processes ensures consistent and reproducible results every time. The
platform also includes the CytoFLEX, CytoFLEX S, and the CytoFLEX LX flow
cytometers, along with the CytoFLEX SRT cell sorter for research, and the
DxFLEX flow cytometer for diagnostic use. *
Polystyrene when triggering on violet side scatter. For Research Use Only
(RUO), not for use in diagnostic procedures.